Advertisement
Research ArticleArticle

INFLUENCE OF ERYTHROMYCIN ON THE PHARMACOKINETICS OF XIMELAGATRAN MAY INVOLVE INHIBITION OF P-GLYCOPROTEIN-MEDIATED EXCRETION

Ulf G. Eriksson, Hassan Dorani, Johan Karlsson, Holger Fritsch, Kurt-Jürgen Hoffmann, Lis Olsson, Troy C. Sarich, Ulrika Wall and Kajs-Marie Schützer
Drug Metabolism and Disposition May 2006, 34 (5) 775-782; DOI: https://doi.org/10.1124/dmd.105.008607

Article Information

vol. 34 no. 5 775-782
DOI 
https://doi.org/10.1124/dmd.105.008607
PubMed 
16455803
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received November 24, 2005
  • Accepted January 30, 2006
  • Published online April 13, 2006.

Article Versions

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Ulf G. Eriksson,
  2. Hassan Dorani,
  3. Johan Karlsson,
  4. Holger Fritsch,
  5. Kurt-Jürgen Hoffmann,
  6. Lis Olsson,
  7. Troy C. Sarich1,
  8. Ulrika Wall and
  9. Kajs-Marie Schützer
  1. AstraZeneca R&D, Mölndal, Sweden
  1. Address correspondence to:
    Ulf G. Eriksson, AstraZeneca R&D, Mölndal, S-431, 83 Mölndal, Sweden. E-mail: ulf.eriksson{at}astrazeneca.com.
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to September 2023

AbstractFullPdf
Aug 201733115
Sep 201714418
Oct 20173269
Nov 201732810
Dec 20175184
Jan 2018132811
Feb 20181155
Mar 201851912
Apr 201822113
May 201802818
Jun 20182215
Jul 201822117
Aug 20180125
Sep 20182133
Oct 20186168
Nov 20187238
Dec 201821914
Jan 20191444
Feb 20191904
Mar 20193519
Apr 20193747
May 20193434
Jun 201943014
Jul 20193303
Aug 20194914
Oct 20193103
Nov 20194501
Dec 20192917
Jan 20206324
Feb 20202811
Mar 20202713
May 2020322
Jun 20201554
Jul 20201202
Aug 2020403
Sep 2020100
Oct 2020402
Nov 2020802
Dec 202028310
Jan 20211146
Feb 20211086
Mar 20212035
Apr 2021921
May 2021930
Jun 20212131
Jul 20211915
Aug 20218262
Sep 2021720
Oct 20211213
Nov 20211215
Dec 20212234
Jan 20221425
Feb 2022710
Mar 20221123
Apr 20222032
May 20222214
Jun 20221910
Jul 20221316
Aug 20221447
Sep 20221731
Oct 20221110
Nov 20222419
Dec 20221110
Jan 20231921
Feb 20231352
Mar 2023514
Apr 2023632
May 20232024
Jun 2023512
Jul 20231322
Aug 202312911
Sep 202315713

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

INFLUENCE OF ERYTHROMYCIN ON THE PHARMACOKINETICS OF XIMELAGATRAN MAY INVOLVE INHIBITION OF P-GLYCOPROTEIN-MEDIATED EXCRETION

Ulf G. Eriksson, Hassan Dorani, Johan Karlsson, Holger Fritsch, Kurt-Jürgen Hoffmann, Lis Olsson, Troy C. Sarich, Ulrika Wall and Kajs-Marie Schützer
Drug Metabolism and Disposition May 1, 2006, 34 (5) 775-782; DOI: https://doi.org/10.1124/dmd.105.008607
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement